QuidelOrtho Corporation (QDEL) Stock Analysis & Winston Score
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instrument
Winston Score: 14/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (6/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (4/15)
Key Facts
Price: $17.38
Market Cap: $1.2B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ
